Brian M. Beyer

818 total citations
19 papers, 558 citations indexed

About

Brian M. Beyer is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Brian M. Beyer has authored 19 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hepatology and 5 papers in Oncology. Recurrent topics in Brian M. Beyer's work include Hepatitis C virus research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Brian M. Beyer is often cited by papers focused on Hepatitis C virus research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Brian M. Beyer collaborates with scholars based in United States, United Kingdom and Japan. Brian M. Beyer's co-authors include Bruce A. Malcolm, Richard Ingram, Ben M. Dunn, Vincent Madison, S. Shane Taremi, Peter Orth, F. George Njoroge, Rumin Zhang, M. Maher and Nanhua Yao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Brian M. Beyer

19 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian M. Beyer United States 12 221 214 134 129 98 19 558
Richard Ingram United States 12 187 0.8× 154 0.7× 182 1.4× 138 1.1× 109 1.1× 14 566
Louise Thauvette Canada 11 222 1.0× 150 0.7× 115 0.9× 187 1.4× 46 0.5× 15 549
John Wickersham United States 8 314 1.4× 340 1.6× 126 0.9× 216 1.7× 140 1.4× 10 724
S. Shane Taremi United States 11 250 1.1× 359 1.7× 159 1.2× 217 1.7× 111 1.1× 14 712
Xiu Yu United States 9 346 1.6× 226 1.1× 185 1.4× 137 1.1× 39 0.4× 11 839
Dawn L. Hall United States 14 508 2.3× 258 1.2× 279 2.1× 234 1.8× 43 0.4× 16 930
Debra Montgomery United States 18 384 1.7× 106 0.5× 185 1.4× 240 1.9× 50 0.5× 31 820
Gulrez Fazal Canada 13 207 0.9× 371 1.7× 267 2.0× 275 2.1× 152 1.6× 16 810
John R. Fulghum United States 10 382 1.7× 394 1.8× 215 1.6× 340 2.6× 108 1.1× 15 797
J. Wielens Australia 14 516 2.3× 51 0.2× 137 1.0× 56 0.4× 58 0.6× 17 740

Countries citing papers authored by Brian M. Beyer

Since Specialization
Citations

This map shows the geographic impact of Brian M. Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Beyer more than expected).

Fields of papers citing papers by Brian M. Beyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Beyer. The network helps show where Brian M. Beyer may publish in the future.

Co-authorship network of co-authors of Brian M. Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Beyer. A scholar is included among the top collaborators of Brian M. Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Beyer. Brian M. Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Fawcett, John, et al.. (2009). Rich Immersive Sports Experience: A Hybrid Multimedia System for Content Consumption. 1–5. 2 indexed citations
3.
Beyer, Brian M., Richard Ingram, Lata Ramanathan, et al.. (2008). Crystal Structures of the Pro-Inflammatory Cytokine Interleukin-23 and Its Complex with a High-Affinity Neutralizing Antibody. Journal of Molecular Biology. 382(4). 942–955. 48 indexed citations
4.
Zhu, Zhaoning, Robert Mazzola, Brian A. McKittrick, et al.. (2008). Discovery of Novel Hydroxamates as Highly Potent Tumor Necrosis Factor-α Converting Enzyme Inhibitors: Part I—Discovery of Two Binding Modes. Journal of Medicinal Chemistry. 51(4). 725–736. 22 indexed citations
5.
Ingram, Richard, Peter Orth, Corey L. Strickland, et al.. (2006). Stabilization of the autoproteolysis of TNF-alpha converting enzyme (TACE) results in a novel crystal form suitable for structure-based drug design studies. Protein Engineering Design and Selection. 19(4). 155–161. 24 indexed citations
6.
Niu, Xiaoda, Shelby P. Umland, Richard Ingram, et al.. (2006). IK682, a tight binding inhibitor of TACE. Archives of Biochemistry and Biophysics. 451(1). 43–50. 46 indexed citations
7.
Wang, Yu‐Sen, Brian M. Beyer, Mary M. Senior, & Daniel F. Wyss. (2005). Characterization of Autocatalytic Conversion of Precursor BACE1 by Heteronuclear NMR Spectroscopy. Biochemistry. 44(50). 16594–16601. 4 indexed citations
8.
Wang, Wenyan, Paul Reichert, Brian M. Beyer, et al.. (2004). Crystallization of glycosylated human BACE protease domain expressed in Trichoplusia ni. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1698(2). 255–259. 4 indexed citations
9.
Wyss, Daniel F., Ashok Arasappan, Mary M. Senior, et al.. (2004). Non-Peptidic Small-Molecule Inhibitors of the Single-Chain Hepatitis C Virus NS3 Protease/NS4A Cofactor Complex Discovered by Structure-Based NMR Screening. Journal of Medicinal Chemistry. 47(10). 2486–2498. 42 indexed citations
10.
Daubaras, Dayna L., Eileen Wilson, Todd A. Black, et al.. (2004). Crystallization and preliminary X-ray analysis of the acyl carrier protein synthase (AcpS) fromStaphylococcus aureus. Acta Crystallographica Section D Biological Crystallography. 60(4). 773–774. 1 indexed citations
11.
Beyer, Brian M., Rumin Zhang, Zhi Hong, Vincent Madison, & Bruce A. Malcolm. (2001). Effect of naturally occurring active site mutations on hepatitis C virus NS3 protease specificity. Proteins Structure Function and Bioinformatics. 43(2). 82–88. 23 indexed citations
12.
Beyer, Brian M., Rumin Zhang, Zhi Hong, Vincent Madison, & Bruce A. Malcolm. (2001). Effect of naturally occurring active site mutations on hepatitis C virus NS3 protease specificity. Proteins Structure Function and Bioinformatics. 43(2). 82–82. 1 indexed citations
13.
Zhang, Rumin, Brian M. Beyer, James Durkin, et al.. (1999). A Continuous Spectrophotometric Assay for the Hepatitis C Virus Serine Protease. Analytical Biochemistry. 270(2). 268–275. 71 indexed citations
14.
Howe, A, Robert A. Chase, S. Shane Taremi, et al.. (1999). A novel recombinant single‐chain hepatitis C virus ns3‐ns4a protein with improved helicase activity. Protein Science. 8(6). 1332–1341. 44 indexed citations
15.
Taremi, S. Shane, Brian M. Beyer, M. Maher, et al.. (1998). Construction, expression, and characterization of a novel fully activated recombinant single‐chain hepatitis C virus protease. Protein Science. 7(10). 2143–2149. 100 indexed citations
16.
Dunn, Ben M., Kōhei Oda, John Kay, et al.. (1998). Comparison of The Specificity of the Aspartic Proteinases Towards Internally Consistent Sets of Oligopeptide Substrates. Advances in experimental medicine and biology. 436. 133–138. 3 indexed citations
17.
Beyer, Brian M., et al.. (1998). Prime region subsite specificity characterization of human cathepsin D: The dominant role of position 128. Protein Science. 7(1). 88–95. 11 indexed citations
18.
Beyer, Brian M. & Ben M. Dunn. (1996). Self-activation of Recombinant Human Lysosomal Procathepsin D at a Newly Engineered Cleavage Junction, “Short” Pseudocathepsin D. Journal of Biological Chemistry. 271(26). 15590–15596. 46 indexed citations
19.
Beyer, Brian M. & Ben M. Dunn. (1995). Site-Directed Mutagenesis of a Disulfide Bridge in Cathepsin D: Expression, Activation, Purification, and Characterization. Advances in experimental medicine and biology. 362. 285–287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Ingram Breakdown of academic impact, for papers by Louise Thauvette Breakdown of academic impact, for papers by John Wickersham Breakdown of academic impact, for papers by S. Shane Taremi Breakdown of academic impact, for papers by Xiu Yu Breakdown of academic impact, for papers by Dawn L. Hall Breakdown of academic impact, for papers by Debra Montgomery Breakdown of academic impact, for papers by Gulrez Fazal Breakdown of academic impact, for papers by John R. Fulghum Breakdown of academic impact, for papers by J. Wielens
Rankless by CCL
2026